Progen Pharmaceuticals issued 101,723,000 shares to Medigen Biotechnology in order to swap shares of its wholly owned subsidiary, TBG Inc. Medigen Biotechnology will raise stake in Progen Pharmaceuticals from 19.7 % to 71.7 %.
Progen Pharmaceuticals issued 101,723,000 shares to Medigen Biotechnology in order to swap shares of its wholly owned subsidiary, TBG Inc. Medigen Biotechnology will raise stake in Progen Pharmaceuticals from 19.7 % to 71.7 %.